<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>Insight数据库 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-14T16:34:43+08:00</updated>
  <subtitle>丁香园 Insight 数据库（db.dxy.cn），拥有申报、临床、上市、药企等 10 大核心数据。致力于分享医药行业政策解读、药企大事和药品申报情报等</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>刚刚！恒瑞「氟唑帕利胶囊」正式获 NMPA 批准上市</title>
    <updated>2020-12-14T15:08:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/EaQ3caImC8ejojhpUT1AAg</id>
    <link href="https://mp.weixin.qq.com/s/EaQ3caImC8ejojhpUT1AAg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>海思科 1 类新药「环泊酚」获批上市</title>
    <updated>2020-12-14T15:08:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/tHwrAewPHOXOc81PGVNXNA</id>
    <link href="https://mp.weixin.qq.com/s/tHwrAewPHOXOc81PGVNXNA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>贝达药业 1 类抗癌新药 BPI-43487 获批临床</title>
    <updated>2020-12-14T15:08:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/iavgDYJ-aAt3pd7wlv17oQ</id>
    <link href="https://mp.weixin.qq.com/s/iavgDYJ-aAt3pd7wlv17oQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今日，第四批国采各省正式启动报量（附最新品规+企业详情）</title>
    <updated>2020-12-12T08:28:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/MGw92lqeU_Nl7KCa32Ic9A</id>
    <link href="https://mp.weixin.qq.com/s/MGw92lqeU_Nl7KCa32Ic9A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今日，11 款仿制药获批，3 款为首家过评</title>
    <updated>2020-12-11T12:07:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/kmbX12DFyASqEinJFBQG0g</id>
    <link href="https://mp.weixin.qq.com/s/kmbX12DFyASqEinJFBQG0g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>默沙东 K 药新适应症国内获批，一线治疗头颈部鳞状细胞癌</title>
    <updated>2020-12-11T12:07:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/H44QI-z-nP_HXgTnEHn6aQ</id>
    <link href="https://mp.weixin.qq.com/s/H44QI-z-nP_HXgTnEHn6aQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>东阳光 1 类新药「磷酸依米他韦胶囊」进入行政审批阶段</title>
    <updated>2020-12-11T12:07:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/1Nd0s-7RWhGvmQrMKQ08qA</id>
    <link href="https://mp.weixin.qq.com/s/1Nd0s-7RWhGvmQrMKQ08qA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>拟突破性疗法！合源生物 CD19 靶向 CAR-T 用于治疗复发/难治 ALL</title>
    <updated>2020-12-11T12:07:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/p2xLa-KTQ3Qe5nqmTIvXSg</id>
    <link href="https://mp.weixin.qq.com/s/p2xLa-KTQ3Qe5nqmTIvXSg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【更新版】药品技术转移、工艺验证和清洁验证最新要求与合规操作</title>
    <updated>2020-12-11T12:07:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/hHvMKFPp4c_nnPL-_WWCEA</id>
    <link href="https://mp.weixin.qq.com/s/hHvMKFPp4c_nnPL-_WWCEA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肝细胞癌术后辅助治疗！恒瑞PD-1+阿帕替尼联合疗法启动 III 期临床</title>
    <updated>2020-12-10T18:28:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/vs4bcjXYG4aa_3Z0e_yzag</id>
    <link href="https://mp.weixin.qq.com/s/vs4bcjXYG4aa_3Z0e_yzag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>再鼎 Repotrectinib 启动临床，ALK/ROS1/NTRK 重排晚期实体瘤</title>
    <updated>2020-12-10T18:28:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/RAwjTqcABbqIenfCuvI1qQ</id>
    <link href="https://mp.weixin.qq.com/s/RAwjTqcABbqIenfCuvI1qQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞「奥贝胆酸片」报上市，国内尚无企业获批</title>
    <updated>2020-12-10T18:28:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/d0u1Rc9Ot0OFHtGnKTVvWw</id>
    <link href="https://mp.weixin.qq.com/s/d0u1Rc9Ot0OFHtGnKTVvWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>齐鲁制药「地夸磷索钠滴眼液」第 2 家报上市</title>
    <updated>2020-12-10T18:28:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/NuRyptj9hjlF_Yk-oDXdzQ</id>
    <link href="https://mp.weixin.qq.com/s/NuRyptj9hjlF_Yk-oDXdzQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！第 4 批国采开始报量，涉及 90 个品规（附品种+企业详情）</title>
    <updated>2020-12-09T13:38:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/50ry7UmsC9hz6lDl0m8BLg</id>
    <link href="https://mp.weixin.qq.com/s/50ry7UmsC9hz6lDl0m8BLg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内首家！恒瑞继续发力眼科领域，「去氧肾上腺素酮咯酸溶液」报上市</title>
    <updated>2020-12-08T18:31:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/DFiL15OFgsCxFC6BWTotGA</id>
    <link href="https://mp.weixin.qq.com/s/DFiL15OFgsCxFC6BWTotGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>生物药峰会！汇聚上海CPhI，5位行业大咖论道生物药研发新趋势！</title>
    <updated>2020-12-08T18:31:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/WVPSuKUTiBbFobMLPeR3Sg</id>
    <link href="https://mp.weixin.qq.com/s/WVPSuKUTiBbFobMLPeR3Sg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>强生 Amivantamab 双抗国内启动 III 期临床，已向 FDA 递交 BLA</title>
    <updated>2020-12-08T18:31:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/tChk_Il871rULf386rxMlw</id>
    <link href="https://mp.weixin.qq.com/s/tChk_Il871rULf386rxMlw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚刚！15 个仿制药获批，10 个仿制药通过一致性评价</title>
    <updated>2020-12-07T18:25:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/HCYCGxsrSSq_qSmNozetOA</id>
    <link href="https://mp.weixin.qq.com/s/HCYCGxsrSSq_qSmNozetOA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>复宏汉霖「阿达木单抗」获批上市</title>
    <updated>2020-12-07T18:25:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/5oynlcGKYM7WyrYc60jOmg</id>
    <link href="https://mp.weixin.qq.com/s/5oynlcGKYM7WyrYc60jOmg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百济神州/安进合作的「注射用倍林妥莫双抗」获批上市</title>
    <updated>2020-12-07T18:25:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/ym9FRGLHFolt1TywBUJriw</id>
    <link href="https://mp.weixin.qq.com/s/ym9FRGLHFolt1TywBUJriw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>